Paroxetine Tablet, Film Coated
Product Images NDC 13107-155

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 13107-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (20 mg 100Tablets Bottle)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC parameters relative to a reference for various interacting drugs: Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis uses a logarithmic scale for change relative to reference, ranging from 0.1 to 10.*

FDA Label Image

Package Label (40 mg 30Tablets Bottle)

A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of several interacting drugs relative to a reference. Drugs listed include Cimetidine 300 mg thrice daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg thrice daily. The x-axis represents change relative to reference from 0 to 2.*

FDA Label Image

Paroxetine Fig3

A pharmacokinetic (PK) chart displaying fold changes and 90% confidence intervals in various populations relative to a reference for paroxetine. It includes groups based on renal impairment (mild, moderate, severe), hepatic impairment, age over 65 with different dosages, and gender (males). Variables shown include Cmax, Cmin, and AUC values on a logarithmic scale with change relative to reference.*

FDA Label Image

Paroxetine Fig4

Label for Paroxetine Tablets USP 10 mg film-coated tablets, containing 30 tablets per package. The label indicates that it is a prescription drug with storage instructions and distributor information for Aurobindo Pharma USA, Inc. The labeler is Aurolife Pharma LLC as per the product data.*

FDA Label Image

Paroxetine Tablets 10mg (100 Count Bottle Label) (Paroxetine Fig5)

Paroxetine Tablets USP 20 mg film-coated tablet label showing NDC 13107-155-30 with dispensing and storage instructions. The label states the active ingredient as paroxetine hydrochloride USP equivalent to 20 mg paroxetine, with a package size of 30 tablets. Distributed by Aurobindo Pharma USA, Inc., Dayton, NJ, the label includes safety closure warnings and pharmacist dispensing guidance.*

FDA Label Image

Paroxetine Tablets 30mg (100 Count Bottle Label) (Paroxetine Fig6)

Paroxetine 30 mg film-coated tablets label from Aurobindo Pharma USA, Inc., containing 30 tablets. The label states the active ingredient as Paroxetine hydrochloride USP equivalent to 30 mg paroxetine per tablet, with storage instructions and usage advisories. The label also includes the product NDC 13107-156-30 and directs pharmacists to dispense with a medication guide.*

FDA Label Image

Paroxetine Fig7

Paroxetine Tablets USP 40 mg film-coated tablet label by Aurobindo Pharma USA, Inc. The label indicates each tablet contains paroxetine hydrochloride equivalent to 40 mg paroxetine. The package contains 30 tablets and includes storage instructions and a note for pharmacists to dispense with a medication guide. UPC and NDC 13107-157-30 are also shown.*

FDA Label Image

Paroxetine Chemical Structure (Paroxetine Str)

Chemical structure of Paroxetine hydrochloride, showing atoms and bonds including a fluorophenyl group, a piperidine ring, and a methylenedioxybenzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.